Limb-girdle Muscular Dystrophy Type 2c
📧 Sign up to get email alerts when something new happens for Limb-girdle Muscular Dystrophy Type 2c.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: ATA-200 Gene Therapy Trial in Patients With LGMDR5 [Phase 1]
The ATA-200 gene therapy trial for LGMD type 2C (Limb-girdle muscular dystrophy type 2C) is in Phase 1 and currently active but not recruiti…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Long-Term Development of Muscular Dystrophy Outcome Assessments
Clinical trial update indicating ongoing recruitment for a long-term study assessing outcome measures in limb-girdle muscular dystrophy acro…
-
CLINICAL_TRIALS withdrawal · 2025-10-06Clinical Trial Update: Natural History Study in Patients With LGMDR5/2c
The natural history study in patients with limb-girdle muscular dystrophy type 2C (gamma-sarcoglycanopathy) sponsored by Atamyo Therapeutics…
-
CLINICAL_TRIALS withdrawal · 2025-08-06Clinical Trial Update: A Study of SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants [Phase 3]
A Phase 3 study evaluating SRP-9005 for Limb-Girdle Muscular Dystrophy Type 2C has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2011-04-29Clinical Trial Update: Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C [Phase 1]
Phase 1 clinical trial evaluating AAV1-gamma-sarcoglycan gene therapy for Limb Girdle Muscular Dystrophy Type 2C (gamma-sarcoglycanopathy) h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.